Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02635672
Title Phase I Dose Escalation Study for BAY 1251152 in Patients With Advanced Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Highlands Oncology Group Springdale Arkansas 72762 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Maryland Oncology Hematology Silver Spring Maryland 20904 United States Details
John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
Willamette Valley Cancer Institute Eugene Oregon 97401 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Avera Health Sioux Falls South Dakota 57105 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
NEXT Oncology Austin Texas 78758 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Centro de Investigaciones Clínicas Viña del Mar Viña Del Mar Valparaíso 2540364 Chile Details
Oncocentro Viña del Mar 2520598 Chile Details
START Madrid- Fundación Jiménez Diaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from for the field